| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.70B | 15.17B | 13.43B | 11.60B | 8.98B | 6.39B |
| Gross Profit | 10.69B | 10.66B | 9.71B | 7.66B | 5.89B | 3.91B |
| EBITDA | 7.57B | 6.99B | 6.67B | 5.29B | 4.03B | 2.53B |
| Net Income | 4.48B | 4.60B | 4.31B | 3.37B | 2.44B | 1.39B |
Balance Sheet | ||||||
| Total Assets | 21.83B | 23.08B | 20.45B | 17.46B | 13.85B | 11.05B |
| Cash, Cash Equivalents and Short-Term Investments | 10.32B | 11.64B | 10.63B | 9.22B | 6.70B | 4.73B |
| Total Debt | 2.06B | 2.17B | 2.06B | 1.93B | 1.80B | 1.69B |
| Total Liabilities | 5.21B | 5.75B | 5.24B | 5.00B | 4.43B | 3.66B |
| Stockholders Equity | 16.60B | 17.33B | 15.20B | 12.44B | 9.40B | 7.38B |
Cash Flow | ||||||
| Free Cash Flow | 5.28B | 5.14B | 3.58B | 3.73B | 2.92B | 1.22B |
| Operating Cash Flow | 5.28B | 5.14B | 4.33B | 4.25B | 3.45B | 1.66B |
| Investing Cash Flow | -1.00B | -1.20B | -995.00M | -646.00M | -716.00M | -453.60M |
| Financing Cash Flow | -3.18B | -3.05B | -1.79B | -1.24B | -869.00M | -810.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $225.61B | 50.44 | 27.36% | 1.21% | 10.31% | 0.54% | |
78 Outperform | €303.82B | 27.77 | 16.88% | 2.08% | -3.24% | -21.24% | |
76 Outperform | €107.80B | 23.66 | 19.54% | 2.29% | -3.24% | -21.65% | |
68 Neutral | €146.16B | 60.64 | 6.19% | 1.24% | 5.45% | 2.86% | |
62 Neutral | €37.11B | 50.91 | 4.91% | 1.87% | -14.56% | -64.91% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |